Seungtaek Kim

3.7k total citations · 2 hit papers
75 papers, 2.4k citations indexed

About

Seungtaek Kim is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Seungtaek Kim has authored 75 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 22 papers in Epidemiology and 21 papers in Hepatology. Recurrent topics in Seungtaek Kim's work include SARS-CoV-2 and COVID-19 Research (30 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (19 papers). Seungtaek Kim is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (30 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (19 papers). Seungtaek Kim collaborates with scholars based in South Korea, United States and Japan. Seungtaek Kim's co-authors include Sangeun Jeon, Meehyun Ko, Jihye Lee, Soonju Park, Inhee Choi, Soo Young Byun, David Shum, Stanley M. Lemon, Min Seong Jang and Sunoh Kwon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Seungtaek Kim

73 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

2020 450 citations Sangeun Jeon, Meehyun Ko et al. Antimicrobial Agents and Chemotherapy profile →
Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

2019 215 citations Min Seong Jang, Hyoung Rae Kim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seungtaek Kim South Korea	24	957	677	586	494	363	75	2.4k
Jin‐Ching Lee Taiwan	35	533 0.6×	1.2k 1.8×	463 0.8×	391 0.8×	81 0.2×	99	3.0k
Leen Vijgen Belgium	23	2.0k 2.0×	363 0.5×	936 1.6×	631 1.3×	112 0.3×	62	3.1k
Egor P. Tchesnokov Canada	24	2.4k 2.5×	856 1.3×	557 1.0×	159 0.3×	355 1.0×	41	3.4k
Lijun Rong United States	36	1.5k 1.6×	1.5k 2.2×	1.3k 2.3×	140 0.3×	255 0.7×	160	4.2k
Leen Delang Belgium	31	1.4k 1.5×	602 0.9×	544 0.9×	273 0.6×	93 0.3×	97	2.7k
Eve‐Isabelle Pécheur France	33	854 0.9×	1.1k 1.6×	1.4k 2.3×	1.2k 2.4×	115 0.3×	68	3.6k
Isabelle Imbert France	19	2.1k 2.2×	869 1.3×	304 0.5×	215 0.4×	374 1.0×	32	3.0k
Thomas Pietschmann Germany	32	683 0.7×	704 1.0×	1.4k 2.3×	1.6k 3.2×	76 0.2×	112	3.5k
Léonardo K. Basco France	34	641 0.7×	523 0.8×	572 1.0×	145 0.3×	748 2.1×	201	4.3k
Shan Cen China	39	1.7k 1.8×	2.4k 3.6×	1.0k 1.7×	223 0.5×	202 0.6×	214	5.2k

Countries citing papers authored by Seungtaek Kim

Since Specialization

Citations

This map shows the geographic impact of Seungtaek Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seungtaek Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seungtaek Kim more than expected).

Fields of papers citing papers by Seungtaek Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seungtaek Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seungtaek Kim. The network helps show where Seungtaek Kim may publish in the future.

Co-authorship network of co-authors of Seungtaek Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Seungtaek Kim. A scholar is included among the top collaborators of Seungtaek Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seungtaek Kim. Seungtaek Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Yu, et al.. (2025). Assessing student satisfaction with university policies related to in-person classes in the era of COVID-19: a case study from Korea. Scientific Reports. 15(1). 9876–9876.

Yoo, Min Heui, et al.. (2024). Potential of 6′‑hydroxy justicidin B from Justicia procumbens as a therapeutic agent against coronavirus disease 2019. Phytomedicine. 134. 156014–156014. 1 indexed citations

Kim, S.-J., Yuri Kim, Sangeun Jeon, et al.. (2024). Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic. Science Advances. 10(9). eadk6425–eadk6425. 1 indexed citations

Im, Keon-Il, Nayoun Kim, Hye Won Lee, et al.. (2024). SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants. International Journal of Molecular Sciences. 25(19). 10512–10512. 1 indexed citations

Ko, Meehyun, Sangeun Jeon, Min Seong Jang, et al.. (2023). Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model. Journal of Medical Virology. 95(6). e28863–e28863. 1 indexed citations

Kim, Kyung‐Ah, Sejoon Lee, Hye Jung Park, et al.. (2023). Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea. Clinical and Molecular Hepatology. 29(2). 496–509. 2 indexed citations

Jin, Young-Hee, Sangeun Jeon, Jihye Lee, et al.. (2022). Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2. Pharmaceutics. 14(2). 376–376. 8 indexed citations

Xing, Jing, Rama Shankar, Meehyun Ko, et al.. (2022). Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants. iScience. 25(10). 105068–105068. 1 indexed citations

Jeon, Sangeun, Min Seong Jang, Seungtaek Kim, et al.. (2022). Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties. Pharmaceuticals. 15(7). 831–831. 7 indexed citations

10.

Valiente, Pedro A., et al.. (2022). Targeting the Receptor-Binding Motif of SARS-CoV-2 with D-Peptides Mimicking the ACE2 Binding Helix: Lessons for Inhibiting Omicron and Future Variants of Concern. Journal of Chemical Information and Modeling. 62(15). 3618–3626. 10 indexed citations

11.

Jeong, Kwiwan, Jinhee Kim, JuOae Chang, et al.. (2022). Chemical screen uncovers novel structural classes of inhibitors of the papain-like protease of coronaviruses. iScience. 25(10). 105254–105254. 6 indexed citations

12.

Xing, Jing, et al.. (2021). Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals. Briefings in Bioinformatics. 22(6). 9 indexed citations

13.

Kim, Sujeong, Sujeong Kim, Hyo‐Jung Lee, et al.. (2021). Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody. Biochemical and Biophysical Research Communications. 545. 33–39. 9 indexed citations

14.

Jeon, Sangeun, Meehyun Ko, Jihye Lee, et al.. (2020). Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrobial Agents and Chemotherapy. 64(7). 450 indexed citations breakdown →

15.

Shin, Eui‐Cheol, Ji Won Han, Wonseok Kang, et al.. (2020). The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses. Viruses. 12(3). 302–302. 3 indexed citations

16.

Harikishore, Amaravadhi, Jihye Lee, Sangeun Jeon, et al.. (2020). Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug. Antiviral Research. 185. 104996–104996. 6 indexed citations

17.

Lee, Jun Young, Sangeun Jeon, Sunoh Kwon, et al.. (2020). Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2. Bioorganic & Medicinal Chemistry Letters. 31. 127667–127667. 26 indexed citations

18.

Jin, Byoungho, Hye Won Lee, Jun Yong Park, et al.. (2018). Evolution and persistence of resistance‐associated substitutions of hepatitis C virus after direct‐acting antiviral treatment failures. Journal of Viral Hepatitis. 25(11). 1251–1259. 14 indexed citations

19.

Kim, Seungtaek, et al.. (2014). Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S). PLoS ONE. 9(12). e113938–e113938. 8 indexed citations

20.

Kim, Beom Kyung, Sung Hyun Ahn, Sung Hyun Ahn, et al.. (2013). Pre‐S mutations of hepatitis B virus affect genome replication and expression of surface antigens. Journal of Gastroenterology and Hepatology. 29(4). 843–850. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact